Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNFalpha levels
A Standard patent application filed on 20 December 2002 credited to Stirling, David I
;
Chen, Roger Shen-Chu
;
Man, Honwah
;
Muller, George W
Details
Application number :
2002320734
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNFalpha levels
Inventor :
Stirling, David I
;
Chen, Roger Shen-Chu
;
Man, Honwah
;
Muller, George W
Agent name :
Pizzeys Patent and Trade Mark Attorneys
Address for service :
Level 20 324 Queen Street Brisbane QLD 4000 Australia
Filing date :
20 December 2002
Associated companies :
Applicant name :
Celgene Corporation
Applicant address :
86 Morris Avenue Summit NJ 07901 United States of America